Ivette Suarrez Arroyo

Address:

Department of Biochemistry,
Universidad Central del Caribe,
School of Medicine,
PO Box 60327 Bayamon,
PR 00960-6032.

Research Interests:

• Breast cancer biology 
• cancer molecular markers
• Metastasis
• EGFR trafficking.

Publications:

• ​Medicines Ganoderma spp.: A Promising Adjuvant Treatment for Breast Cancer.
• The proteome signature of the inflammatory breast cancer plasma membrane identifies novel molecular markers of disease.
• Ganoderma lucidum Combined with the EGFR Tyrosine Kinase Inhibitor, Erlotinib Synergize to Reduce Inflammatory Breast Cancer Progression.
• Abstract B20: Combination of Ganoderma lucidum extract and erlotinib decreases IBC progression.
• PO133 DIFFERENTIAL EXPRESSION OF PLASMA MEMBRANE PROTEINS IN INFLAMMATORY BREAST CANCER VIA STABLE ISOTOPE LABELED AMINO ACIDS IN CULTURE (SILAC).
• Abstract 5556: Enhancing response of Ganoderma lucidum (Reishi) and lapatinib in HER2+ inflammatory breast cancer cells.
• Abstract 3219: Synergistic effect between Ganoderma lucidum (Reishi) and lapatinib in HER2+ inflammatory breast cancer cells.
• Abstract 3212: Ganoderma lucidum (Reishi) chemosensitizes EGFR-overexpressing inflammatory breast cancer cells to erlotinib.
• Abstract 2247: Ganoderma lucidum (Reishi) downregulates key proteins overexpressed in IBC and chemosensitizes EGFR-overexpressing cells to erlotinib.
• Abstract 1672: Ganoderma lucidum (Reishi) induces autophagy in inflammatory breast cancer cells to promote cell death.
• Anti-Tumor Effects of Ganoderma lucidum (Reishi) in Inflammatory Breast Cancer in In Vivo and In Vitro Models.
• Abstract 1987: Ganoderma lucidum (Reishi) suppresses key protein synthesis initiation molecules in inflammatory breast cancer.
• Abstract 1992: Ganoderma lucidum (Reishi) induces autophagy in inflammatory breast cancer by regulation of the mTOR signaling pathway.